JWH-307
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H24FNO |
| Molar mass | 385.472 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB2 subtype, with a Ki of 7.7nM at CB1 vs 3.3nM at CB2.[1] It was discovered by, and named after, Dr. John W. Huffman. JWH-307 was detected as an ingredient in synthetic cannabis smoking blends in 2012, initially in Germany.[2][3]
See also
References
- ^ Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters 2006; 16:5432-5435.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22748479, please use {{cite journal}} with
|pmid=22748479instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22791249, please use {{cite journal}} with
|pmid=22791249instead.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |